TXL may probably exhibit a specific advantage in the prevention and treatment of myocardial fibrosis via mediating the expressions of TGF-beta1, Smad3, and Smad7 in diabetic rats (Wang X. et al., 2016). The gene discussed is SMAD7; the disease is Myocardial fibrosis.